Multi-mer peptides derived from hepatitis C virus envelope...

Details Multi-mer peptides derived from hepatitis C virus envelope... Multi-mer peptides derived from hepatitis C virus envelope...

2005-02-15

2005-02-15

Housel, James (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S228100, C514S002600, C435S005000, C435S007100, C435S007920, C435S069100, C435S069300

Reexamination Certificate

active

06855318

ABSTRACT:
Multimer peptides (e.g. 30- to 45-mer peptides) derived from hepatitis C virus envelope proteins reacting with the majority of anti-HCV antibodies present in patient sera are described. The usage of the latter peptides to diagnose, and to vaccinate against, an infection with hepatitis C virus is also disclosed.

REFERENCES:
patent: 5670153 (1997-09-01), Weiner et al.
patent: 5747239 (1998-05-01), Wang et al.
patent: 0 445 423 (1991-09-01), None
patent: 0 468 527 (1992-01-01), None
patent: WO 93 02103 (1993-02-01), None
patent: WO 93 06247 (1993-04-01), None
patent: WO 93 06488 (1993-04-01), None
patent: WO9318054 (1993-09-01), None
patent: WO 94 25874 (1994-11-01), None
patent: WO 95 12677 (1995-05-01), None
patent: WO 95 32291 (1995-11-01), None
patent: WO 96 04385 (1996-02-01), None

Affiliated with

Also associated with

Rating

Multi-mer peptides derived from hepatitis C virus envelope... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multi-mer peptides derived from hepatitis C virus envelope..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-mer peptides derived from hepatitis C virus envelope... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3458793